The U.S. Food and Drug Administration told EpiPen’s maker, Pfizer Inc., this week that it failed to properly investigate reports of malfunctioning auto-injectors, including incidents associated with patient deaths and severe illness.
The U.S. Food and Drug Administration told EpiPen’s maker, Pfizer Inc., this week that it failed to properly investigate reports of malfunctioning auto-injectors, including incidents associated with patient deaths and severe illness.